Kevin D. Houston

511 total citations
22 papers, 418 citations indexed

About

Kevin D. Houston is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Kevin D. Houston has authored 22 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Kevin D. Houston's work include Estrogen and related hormone effects (6 papers), Single-cell and spatial transcriptomics (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Kevin D. Houston is often cited by papers focused on Estrogen and related hormone effects (6 papers), Single-cell and spatial transcriptomics (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Kevin D. Houston collaborates with scholars based in United States. Kevin D. Houston's co-authors include Jessica P. Houston, Zheng Yan, Ali Vaziri‐Gohar, Russell R. Broaddus, Cheryl L. Walker, John A. Copland, Mark J. Walker, Deborah Hunter, Leslie Hodges-Gallagher and Marco M. Gottardis and has published in prestigious journals such as Cancer Research, Scientific Reports and The FASEB Journal.

In The Last Decade

Kevin D. Houston

19 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin D. Houston United States 13 228 78 76 58 55 22 418
Raphael Heilig United Kingdom 10 271 1.2× 45 0.6× 35 0.5× 101 1.7× 26 0.5× 18 418
Léa Delbos France 8 207 0.9× 153 2.0× 171 2.3× 112 1.9× 12 0.2× 18 521
Л. В. Спирина Russia 12 238 1.0× 18 0.2× 16 0.2× 121 2.1× 29 0.5× 95 430
Arindam Paul United States 8 300 1.3× 27 0.3× 18 0.2× 75 1.3× 88 1.6× 8 398
Namrata Kumar United States 10 346 1.5× 26 0.3× 6 0.1× 56 1.0× 28 0.5× 12 468
Elangovan Thavathiru United States 12 219 1.0× 20 0.3× 28 0.4× 59 1.0× 50 0.9× 16 371
Sandra Pierredon France 13 576 2.5× 22 0.3× 17 0.2× 238 4.1× 60 1.1× 16 732
Zannel Blanchard United States 8 183 0.8× 77 1.0× 54 0.7× 100 1.7× 83 1.5× 11 383
Christoph Schatz Austria 10 688 3.0× 30 0.4× 46 0.6× 43 0.7× 26 0.5× 26 827
Núria Eritja Spain 6 209 0.9× 94 1.2× 71 0.9× 110 1.9× 27 0.5× 10 409

Countries citing papers authored by Kevin D. Houston

Since Specialization
Citations

This map shows the geographic impact of Kevin D. Houston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin D. Houston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin D. Houston more than expected).

Fields of papers citing papers by Kevin D. Houston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin D. Houston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin D. Houston. The network helps show where Kevin D. Houston may publish in the future.

Co-authorship network of co-authors of Kevin D. Houston

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin D. Houston. A scholar is included among the top collaborators of Kevin D. Houston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin D. Houston. Kevin D. Houston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Houston, Kevin D., et al.. (2024). Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer. Frontiers in Endocrinology. 15. 1450648–1450648.
4.
Yan, Zheng, et al.. (2021). Investigating differences between tamoxifen resistant and sensitive breast cancer cells with flow cytometry. Cytometry Part A. 99(2). 164–169. 4 indexed citations
5.
Yan, Zheng, et al.. (2020). IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation. Frontiers in Endocrinology. 11. 233–233. 22 indexed citations
6.
Yan, Zheng & Kevin D. Houston. (2019). Glucose-dependent GPER1 expression modulates tamoxifen-induced IGFBP-1 accumulation. Journal of Molecular Endocrinology. 63(2). 103–112. 6 indexed citations
7.
Houston, Kevin D., et al.. (2018). Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time‐resolved flow cytometry. Cytometry Part A. 95(1). 70–79. 18 indexed citations
8.
Vaziri‐Gohar, Ali, Zheng Yan, & Kevin D. Houston. (2017). IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells. Molecular Cancer Research. 15(4). 489–497. 22 indexed citations
9.
Li, Wenyan, Kevin D. Houston, & Jessica P. Houston. (2017). Shifts in the fluorescence lifetime of EGFP during bacterial phagocytosis measured by phase-sensitive flow cytometry. Scientific Reports. 7(1). 40341–40341. 21 indexed citations
11.
Vaziri‐Gohar, Ali & Kevin D. Houston. (2015). GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells. Molecular and Cellular Endocrinology. 422. 160–171. 12 indexed citations
12.
Li, Wenyan, et al.. (2014). Fluorescence lifetime excitation cytometry by kinetic dithering. Electrophoresis. 35(12-13). 1846–1854. 15 indexed citations
13.
Vaziri‐Gohar, Ali, Ruofan Cao, Patrick Jenkins, et al.. (2013). Subcellular localization-dependent changes in EGFP fluorescence lifetime measured by time-resolved flow cytometry. Biomedical Optics Express. 4(8). 1390–1390. 28 indexed citations
14.
Short, John D., Ruhee Dere, Kevin D. Houston, et al.. (2010). AMPK‐mediated phosphorylation of murine p27 at T197 promotes binding of 14‐3‐3 proteins and increases p27 stability. Molecular Carcinogenesis. 49(5). 429–439. 36 indexed citations
15.
Short, John D., Kevin D. Houston, Ruhee Dere, et al.. (2008). AMP-Activated Protein Kinase Signaling Results in Cytoplasmic Sequestration of p27. Cancer Research. 68(16). 6496–6506. 46 indexed citations
16.
Bakthavatsalam, Deenadayalan, et al.. (2008). The secretedDictyosteliumprotein CfaD is a chalone. Journal of Cell Science. 121(15). 2473–2480. 44 indexed citations
17.
Houston, Kevin D.. (2004). Convergent etiology of Eker rat and human uterine leiomyoma. DigtalCommons @ Texas Medical Center Library (Texas Medical Center). 1 indexed citations
18.
Houston, Kevin D., John A. Copland, Russell R. Broaddus, et al.. (2003). Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma.. PubMed. 63(6). 1221–7. 67 indexed citations
19.
Houston, Kevin D., et al.. (2003). Uterine Leiomyomas Express Myometrial Contractile-Associated Proteins Involved in Pregnancy-Related Hormone Signaling. Journal of the Society for Gynecologic Investigation. 10(1). 11–20. 13 indexed citations
20.
Hodges-Gallagher, Leslie, Kevin D. Houston, Deborah Hunter, et al.. (2002). Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells. Molecular and Cellular Endocrinology. 196(1-2). 11–20. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026